{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T09:16:29Z","timestamp":1777972589712,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10620-025-09485-y","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:43:23Z","timestamp":1761536603000},"page":"1512-1521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Outcomes of Intravenous Albumin Administration After Acute Variceal Hemorrhage in Patients with Cirrhosis: An Open-Label, Randomized Controlled Trial"],"prefix":"10.1007","volume":"71","author":[{"given":"Sagnik","family":"Biswas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubham","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shekhar","family":"Swaroop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnav","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayush","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarthak","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samagra","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanchita","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivanand","family":"Gamanagatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Shalimar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"9485_CR1","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jhep.2020.11.048","volume":"74","author":"V Arroyo","year":"2021","unstructured":"Arroyo V, Angeli P, Moreau R et al. The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis. J Hepatol 2021;74:670\u2013685.","journal-title":"J Hepatol"},{"key":"9485_CR2","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2020.06.013","volume":"73","author":"J Trebicka","year":"2020","unstructured":"Trebicka J, Fernandez J, Papp M et al. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology. J Hepatol 2020;73:842\u2013854.","journal-title":"J Hepatol"},{"key":"9485_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","volume":"60","author":"R Wiest","year":"2014","unstructured":"Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol 2014;60:197\u2013209.","journal-title":"J Hepatol"},{"key":"9485_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jhep.2014.03.014","volume":"61","author":"G Mehta","year":"2014","unstructured":"Mehta G, Gustot T, Mookerjee RP et al. Inflammation and portal hypertension\u2014the undiscovered country. J Hepatol 2014;61:155\u2013163.","journal-title":"J Hepatol"},{"key":"9485_CR5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jhep.2020.10.004","volume":"74","author":"D Costa","year":"2021","unstructured":"Costa D, Simbrunner B, Jachs M et al. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality. J Hepatol 2021;74:819\u2013828.","journal-title":"J Hepatol"},{"key":"9485_CR6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/HEP.0000000000000521","volume":"81","author":"J Trebicka","year":"2025","unstructured":"Trebicka J, Garcia-Tsao G. Controversies regarding albumin therapy in cirrhosis. Hepatology (Baltim Md) 2025;81:288\u2013303.","journal-title":"Hepatology (Baltim Md)"},{"key":"9485_CR7","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","volume":"391","author":"P Caraceni","year":"2018","unstructured":"Caraceni P, Riggio O, Angeli P et al. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. Lancet 2018;391:2417\u20132429.","journal-title":"Lancet"},{"key":"9485_CR8","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jhep.2018.08.006","volume":"69","author":"E Sol\u00e0","year":"2018","unstructured":"Sol\u00e0 E, Sol\u00e9 C, Sim\u00f3n-Talero M et al. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial. J Hepatol 2018;69:1250\u20131259.","journal-title":"J Hepatol"},{"key":"9485_CR9","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U","volume":"32","author":"P Ahmad-Nejad","year":"2002","unstructured":"Ahmad-Nejad P, H\u00e4cker H, Rutz M, Bauer S, Vabulas RM, Wagner H. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur J Immunol 2002;32:1958\u20131968.","journal-title":"Eur J Immunol"},{"key":"9485_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100807","author":"J Cl\u00e0ria","year":"2023","unstructured":"Cl\u00e0ria J, Arroyo V, Moreau R. Roles of systemic inflammatory and metabolic responses in the pathophysiology of acute-on-chronic liver failure. JHEP Rep. 2023. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100807.","journal-title":"JHEP Rep"},{"key":"9485_CR11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jhep.2023.04.021","volume":"79","author":"R Moreau","year":"2023","unstructured":"Moreau R, Tonon M, Krag A et al. EASL Clinical Practice Guidelines on acute-on-chronic liver failure. J Hepatol 2023;79:461\u2013491.","journal-title":"J Hepatol"},{"key":"9485_CR12","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1097\/HEP.0000000000000647","volume":"79","author":"DE Kaplan","year":"2024","unstructured":"Kaplan DE, Ripoll C, Thiele M et al. AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis. Hepatology 2024;79:1180.","journal-title":"Hepatology"},{"key":"9485_CR13","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R de Franchis","year":"2022","unstructured":"de Franchis R, Bosch J, Garcia-Tsao G et al. Baveno VII\u2014renewing consensus in portal hypertension. J Hepatol 2022;76:959\u2013974.","journal-title":"J Hepatol"},{"key":"9485_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101325","volume":"7","author":"V Perez-Campuzano","year":"2025","unstructured":"Perez-Campuzano V, Olivas P, Ferrusqu\u00eda-Acosta J et al. Hemodynamic profile of terlipressin and octreotide in patients with cirrhosis and portal hypertension: a randomized, single-blind clinical trial. JHEP Rep 2025;7:101325.","journal-title":"JHEP Rep"},{"key":"9485_CR15","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"P Angeli","year":"2018","unstructured":"Angeli P, Bernardi M, Villanueva C et al. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol 2018;69:406\u2013460.","journal-title":"J Hepatol"},{"key":"9485_CR16","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/liv.15559","volume":"43","author":"L Turco","year":"2023","unstructured":"Turco L, Reiberger T, Vitale G, La Mura V. Carvedilol as the new non-selective beta-blocker of choice in patients with cirrhosis and portal hypertension. Liver Int 2023;43:1183\u20131194.","journal-title":"Liver Int"},{"key":"9485_CR17","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jhep.2022.06.001","volume":"77","author":"S Montagnese","year":"2022","unstructured":"Montagnese S, Rautou P-E, Romero-G\u00f3mez M et al. EASL Clinical Practice Guidelines on the management of hepatic encephalopathy. J Hepatol 2022;77:807\u2013824.","journal-title":"J Hepatol"},{"key":"9485_CR18","first-page":"954","volume":"23","author":"S Biswas","year":"2024","unstructured":"Biswas S, Vaishnav M, Gamanagatti S et al. Endoscopic glue injection vs glue plus BRTO or TIPSS for preventing gastric variceal bleeding: a randomized controlled trial. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 2024;23:954-964.e10.","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"9485_CR19","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/apt.17868","volume":"59","author":"M Vaishnav","year":"2024","unstructured":"Vaishnav M, Biswas S, Shenoy A et al. Comparison of 1-day versus 3-day intravenous terlipressin in cirrhosis patients with variceal bleeding: a pilot randomised controlled trial. Aliment Pharmacol Ther 2024;59:645\u2013655.","journal-title":"Aliment Pharmacol Ther"},{"key":"9485_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14309\/ajg.0000000000002776","volume":"3","author":"G-H Lo","year":"2024","unstructured":"Lo G-H, Yeh J-H, Tseng C-H et al. A noninferiority trial comparing 2 days vs 5 days of terlipressin and ceftriaxone in terms of 5-day rebleeding for patients with acute gastroesophageal variceal hemorrhage. Am J Gastroenterol 2024;3:1. https:\/\/doi.org\/10.14309\/ajg.0000000000002776 (published online 30 April).","journal-title":"Am J Gastroenterol"},{"key":"9485_CR21","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/HEP.0000000000000817","volume":"80","author":"M Kumar","year":"2024","unstructured":"Kumar M, Venishetty S, Jindal A et al. Tranexamic acid in upper gastrointestinal bleed in patients with cirrhosis: a randomized controlled trial. Hepatology (Baltim Md) 2024;80:376\u2013388.","journal-title":"Hepatology (Baltim Md)"},{"key":"9485_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c2697","volume":"340","author":"I Abraha","year":"2010","unstructured":"Abraha I, Montedori A. Modified intention to treat reporting in randomised controlled trials: systematic review. BMJ 2010;340:c2697.","journal-title":"BMJ"},{"key":"9485_CR23","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1097\/EDE.0000000000001755","volume":"35","author":"G Wang","year":"2024","unstructured":"Wang G, Hamad R, White JS. Advances in difference-in-differences methods for policy evaluation research. Epidemiology (Camb Mass) 2024;35:628.","journal-title":"Epidemiology (Camb Mass)"},{"key":"9485_CR24","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jhep.2019.11.009","volume":"72","author":"R Moreau","year":"2020","unstructured":"Moreau R, Cl\u00e0ria J, Aguilar F et al. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF. J Hepatol 2020;72:688\u2013701.","journal-title":"J Hepatol"},{"key":"9485_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1053\/j.gastro.2019.03.021","volume":"157","author":"J Fern\u00e1ndez","year":"2019","unstructured":"Fern\u00e1ndez J, Cl\u00e0ria J, Amor\u00f3s A et al. Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis. Gastroenterology 2019;157:149\u2013162.","journal-title":"Gastroenterology"},{"key":"9485_CR26","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.cgh.2016.05.040","volume":"14","author":"AM Moon","year":"2016","unstructured":"Moon AM, Dominitz JA, Ioannou GN, Lowy E, Beste LA. Use of antibiotics among patients with cirrhosis and upper gastrointestinal bleeding is associated with reduced mortality. Clin Gastroenterol Hepatol 2016;14:1629-1637.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9485_CR27","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1097\/HEP.0000000000000793","volume":"80","author":"YJ Wong","year":"2024","unstructured":"Wong YJ, Teng M, Sim A et al. Full adherence to cirrhosis quality indicators is associated with lower mortality in acute variceal bleeding: nationwide audit. Hepatology (Baltim Md) 2024;80:872\u2013886.","journal-title":"Hepatology (Baltim Md)"},{"key":"9485_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2025.101941","volume":"30","author":"N Torp","year":"2025","unstructured":"Torp N, China L, Israelsen M et al. Targeted albumin infusions in hospitalized patients with cirrhosis receiving terlipressin: a post-hoc analysis of ATTIRE. Ann Hepatol 2025;30:101941.","journal-title":"Ann Hepatol"},{"key":"9485_CR29","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1056\/NEJMoa2022166","volume":"384","author":"L China","year":"2021","unstructured":"China L, Freemantle N, Forrest E et al. A randomized trial of albumin infusions in hospitalized patients with cirrhosis. N Engl J Med 2021;384:808\u2013817.","journal-title":"N Engl J Med"},{"key":"9485_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100785","volume":"5","author":"Z Bai","year":"2023","unstructured":"Bai Z, M\u00e9ndez-S\u00e1nchez N, Romeiro FG et al. Use of albumin infusion for cirrhosis-related complications: an international position statement. JHEP Rep 2023;5:100785.","journal-title":"JHEP Rep"},{"key":"9485_CR31","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cgh.2014.11.019","volume":"13","author":"P Tandon","year":"2015","unstructured":"Tandon P, Abraldes JG, Keough A et al. Risk of bacterial infection in patients with cirrhosis and acute variceal hemorrhage, based on Child-Pugh class, and effects of antibiotics. Clin Gastroenterol Hepatol 2015;13:1189-1196.e2.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9485_CR32","doi-asserted-by":"publisher","first-page":"1437.e1","DOI":"10.1053\/j.gastro.2013.02.042","volume":"144","author":"R Moreau","year":"2013","unstructured":"Moreau R, Jalan R, Gines P et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013;144:1437.e1\u20139.","journal-title":"Gastroenterology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09485-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09485-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09485-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T08:42:47Z","timestamp":1777970567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09485-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["9485"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09485-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"13 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}